Dr. Dale E Buonocore, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 33 Main Dr, North Warren, PA 16365 Phone: 814-726-4317 Fax: 814-726-4447 |
News Archive
A new study published on the preprint server bioRxiv* in August 2020 shows that the man-made compound silicon nitride, which is used in medical implants and high mechanical performance engineering applications, is capable of inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at varying concentrations without causing cell cytotoxicity. This finding should be investigated to develop disinfectants to clear the virus from surfaces, preventing its spread.
Researchers at the University of Warwick have discovered diabetes could be a hidden condition for some patients with coronary heart disease.
Cegedim Dendrite, the world's leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced today that Boryung Pharmaceutical Co., Ltd., has implemented Cegedim Dendrite's Mobile Intelligenceā¢ CRM solution. Boryung Pharmaceutical is one of Korea's top 10 domestic pharmaceutical companies, and Cegedim Dendrite currently serves 14 of the industry's top-grossing companies in Korea.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
› Verified 9 days ago